Market Tracker

05/27 3:33am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

6.28
Delayed Data
As of May 26
 -0.10 / -1.57%
Today’s Change
6.03
Today|||52-Week Range
12.88
-33.12%
Year-to-Date

Today’s Trading

Previous close6.38
Today’s open6.37
Day’s range6.25 - 6.42
Volume646,524
Average volume (3 months)1,245,571
Market cap$277.8M
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-34.41%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...-0.01-0.26%
VTAEVitae Pharmaceutical...-0.38-3.01%
AMBIAmbit Biosciences Co...----
TRVNTrevena Inc-0.02-0.29%
Data as of 3:59pm ET, 05/26/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts